RxDoctor Payments Data

Stefan Holubar, MD

Colon & Rectal Surgery · Cleveland, OHNPI 1033313747

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,780 of the $12,326 with a category attached, or 79.3%. 12 manufacturers reported payments, led by Shionogi Inc at 54.4% of the total. Reporting peaked in 2020 at $6,920 and has fallen 86.2% since, to $952 in 2025. Among colon & rectal surgery clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,326in general payments, 2019–2025

Across 30 payments — averaging $410.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shionogi Inc$7K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • Johnson & Johnson$1K
  • Baxter Healthcare$370
  • AbbVie$175
  • Dilon Technologies, Inc.$159
  • plus $659 from 6 others
$33,579in research payments, 2019–2025

Across 6 payments — averaging $5596.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$34K

What the payments were for

  • Consulting fees$9,78079%
  • Food & beverage$2,54621%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,326 in reported general payments places this provider in the 90th percentile of 101 colon & rectal surgery providers in Ohio.

See all colon & rectal surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$66,215
Medicare patients
91
Services billed
312

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine17$1,189
Lactated RingersRinger's Solution,lactated12$215
Neomycin Sulfate16$61
Metronidazole15$17

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →